Yttrium-90 microsphere selective internal radiation therapy for liver metastases following systemic chemotherapy and surgical resection for metastatic adrenocortical carcinoma

Figure 2 Yttrium-90 planning and radioembolization for treatment of liver metastases from adrenocortical carcinoma. A: Representative coronal CT abdomen image obtained prior to locoregional therapy shows low density lesions within the liver (arrow) consistent with metastatic disease; B: Three-dimensional reconstructions of the liver used for Yttrium-90 dose calculations revealed a proposed treatment volume of 409 mL for the left hepatic lobe (green colored, arrow) and 1339 mL for the right hepatic lobe (yellow colored, arrowhead) for a total hepatic volume of 1749 mL; C: Digitally subtracted contrast angiography reveals numerous hypervascular metastases within the right and left hepatic lobes (representative right hepatic lobe lesion demarked by arrow).